ES2160090A1 - Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration - Google Patents
Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administrationInfo
- Publication number
- ES2160090A1 ES2160090A1 ES200000635A ES200000635A ES2160090A1 ES 2160090 A1 ES2160090 A1 ES 2160090A1 ES 200000635 A ES200000635 A ES 200000635A ES 200000635 A ES200000635 A ES 200000635A ES 2160090 A1 ES2160090 A1 ES 2160090A1
- Authority
- ES
- Spain
- Prior art keywords
- cyprofloxacin
- otitis
- aqueous
- single dose
- comprises single
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
The set of aqueous cyprofloxacin otitis pharmaceuticals comprising single-dose products for treatment of perforated-eardrum patients, is new. Also claimed is a process utilizing the products in the form of droplets, topically, from single-dose containers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000635A ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000635A ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2160090A1 true ES2160090A1 (en) | 2001-10-16 |
ES2160090B1 ES2160090B1 (en) | 2002-07-01 |
Family
ID=8492728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200000635A Expired - Fee Related ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2160090B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005077360A2 (en) * | 2004-02-05 | 2005-08-25 | Fairfield Clinical Trials, Llc | Topical treatment of otitis externa with antifungals or antibacterials |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2088742A1 (en) * | 1994-06-29 | 1996-08-16 | Salvat Lab Sa | Antibiotic preparation for aural application |
WO1996039146A1 (en) * | 1995-06-06 | 1996-12-12 | Bayer Corporation | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
EP0763359A1 (en) * | 1995-07-14 | 1997-03-19 | R.R.A. S.r.l. | Pharmaceutical composition for topical use |
ES2105971A1 (en) * | 1995-08-02 | 1997-10-16 | S A L V A T Lab Sa | Antibiotic/anti-inflammatory composition for otic application. |
ES2105970A1 (en) * | 1995-08-02 | 1997-10-16 | S A L V A T Lab Sa | Oral pharmaceutical composition of ciprofloxacin, non- aqueous, stable and with improved organoleptic characteristics. |
ES2106680A1 (en) * | 1995-08-03 | 1997-11-01 | Vita Invest Sa | Aqueous compositions containing ciprofloxacine, and related use and process |
US5843930A (en) * | 1995-06-06 | 1998-12-01 | Bayer Corporation | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
-
2000
- 2000-03-16 ES ES200000635A patent/ES2160090B1/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2088742A1 (en) * | 1994-06-29 | 1996-08-16 | Salvat Lab Sa | Antibiotic preparation for aural application |
WO1996039146A1 (en) * | 1995-06-06 | 1996-12-12 | Bayer Corporation | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
US5843930A (en) * | 1995-06-06 | 1998-12-01 | Bayer Corporation | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
EP0763359A1 (en) * | 1995-07-14 | 1997-03-19 | R.R.A. S.r.l. | Pharmaceutical composition for topical use |
ES2105971A1 (en) * | 1995-08-02 | 1997-10-16 | S A L V A T Lab Sa | Antibiotic/anti-inflammatory composition for otic application. |
ES2105970A1 (en) * | 1995-08-02 | 1997-10-16 | S A L V A T Lab Sa | Oral pharmaceutical composition of ciprofloxacin, non- aqueous, stable and with improved organoleptic characteristics. |
ES2106680A1 (en) * | 1995-08-03 | 1997-11-01 | Vita Invest Sa | Aqueous compositions containing ciprofloxacine, and related use and process |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005077360A2 (en) * | 2004-02-05 | 2005-08-25 | Fairfield Clinical Trials, Llc | Topical treatment of otitis externa with antifungals or antibacterials |
WO2005077360A3 (en) * | 2004-02-05 | 2005-11-10 | Fairfield Clinical Trials Llc | Topical treatment of otitis externa with antifungals or antibacterials |
Also Published As
Publication number | Publication date |
---|---|
ES2160090B1 (en) | 2002-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA74346C2 (en) | Aminodicarboxylic acids derivatives, use thereof and a medicament | |
MX9602683A (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances. | |
MX9601399A (en) | Benzocyclopentane oxazolidones containing heteroatoms, process for their production and medicaments containing them. | |
MXPA03007712A (en) | Pharmaceutical salts. | |
BR0112591A (en) | Acridine derivatives and their application as a medicine | |
CA2272584A1 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
CA2257329A1 (en) | Nebulized budesonide for the treatment of respiratory diseases | |
IL136839A0 (en) | Pharmaceutical compositions comprising cannabidiol derivatives | |
MX9605023A (en) | Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances. | |
PT703786E (en) | USE OF NONAPEPTIDEES AND DECAPEPTIDEOS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AIDS | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
IL152578A0 (en) | Ortho-substituted anthranilic acid amides and their use as medicaments | |
CA2189916A1 (en) | A new regime for paclitaxel in kaposi's sarcoma patients | |
IS6394A (en) | Medicinal product containing solmitriptan | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
AU5372199A (en) | Cyclopentabenzofuran derivatives and their use | |
HK1079688A1 (en) | Statin product for enhancing cognitive maintenance | |
PL348781A1 (en) | Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition | |
ES2160090A1 (en) | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration | |
WO2001076590A3 (en) | Treatment for benign positional vertigo using antiepileptics | |
MY127328A (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
WO2002041897A3 (en) | Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same | |
ZA200100289B (en) | Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis. | |
PL367628A1 (en) | Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia | |
WO2000067733A3 (en) | Medicament for treating human infertility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20011016 Kind code of ref document: A1 Effective date: 20011016 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20200626 |